The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK...

Saved in:
Bibliographic Details
Title: The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK...
Authors: Oosterveld, M, Suciu, S, Verhoef, G, Labar, B, Belhabri, A, Aul, C, Selleslag, D, Ferrant, A, Wijermans, P, Mandelli, F, Amadori, S, Jehn, U, Muus, P, Zittoun, R, Hess, U, Anak, O, Beeldens, F, Willemze, R, de Witte, T
Source: Leukemia (08876924). May2003, Vol. 17 Issue 5, p859. 10p.
Database: Academic Search Ultimate
Description
ISSN:08876924
DOI:10.1038/sj.leu.2402897